Net Cash Provided by (Used in) Operating Activities |
-27.4K |
USD |
-174% |
Q4 2023 |
Q1 2024 |
Net Cash Provided by (Used in) Financing Activities |
50.3K |
USD |
+151% |
Q4 2023 |
Q1 2024 |
Common Stock, Shares Authorized |
500M |
shares |
0% |
Q1 2024 |
Q2 2024 |
Common Stock, Shares, Issued |
425M |
shares |
+13.5% |
Q1 2024 |
Q2 2024 |
Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q1 2024 |
Q2 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
22.7K |
USD |
+122% |
Q4 2023 |
Q1 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
2.86K |
USD |
-23.4% |
Q3 2022 |
FY 2022 |
Depreciation |
84 |
USD |
+1.21% |
Q4 2023 |
Q1 2024 |
Property, Plant and Equipment, Gross |
78K |
USD |
-0.68% |
Q3 2023 |
FY 2023 |
Preferred Stock, Shares Issued |
0 |
shares |
|
Q1 2024 |
Q2 2024 |
Preferred Stock, Shares Authorized |
10M |
shares |
0% |
Q1 2024 |
Q2 2024 |
Additional Paid in Capital |
64M |
USD |
+0.57% |
Q1 2024 |
Q2 2024 |
Preferred Stock, Shares Outstanding |
0 |
shares |
|
Q1 2024 |
Q2 2024 |
Share-based Payment Arrangement, Expense |
44.4K |
USD |
|
Q4 2023 |
Q1 2024 |
Interest Expense |
35.8K |
USD |
+79.5% |
Q1 2024 |
Q2 2024 |
Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q1 2024 |
Q2 2024 |